Director Jeffrey Albers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

On September 28, 2023, Jeffrey Albers, a director at Blueprint Medicines Corp (NASDAQ:BPMC), sold 25,000 shares of the company's stock.

Jeffrey albersBlueprint medicines corpGurufocus valueDirector jeffrey albersBlueprint medicinesJeffrey albersNsider transactionsBlueprint medicines corp